This is Thomas Sullivan's Typepad Profile.
Join Typepad and start following Thomas Sullivan's activity
Join Now!
Already a member? Sign In
Thomas Sullivan
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
A recent study in the journal Pain Medicine, looking at the impact of continuing medical education (CME) on opioid prescribing found that educating clinicians on how to safely prescribe opioids can help decrease misuse among chronic pain sufferers. While untreated... Continue reading
Posted yesterday at Policy and Medicine
Image
Life science compliance conferences are an important way for compliance professionals and healthcare attorneys to stay on top of changing regulations, enforcement priorities, and best practices within the industry. Furthermore, conferences offer the opportunity to network with a diverse group... Continue reading
Posted 2 days ago at Policy and Medicine
Image
Earlier this week, EFPIA, Europe's pharmaceutical industry association, announced it had filed a complaint with the European Commission against the French “RTU Regime.” promoting the use of Roche's cancer drug Avastin for the off-label treatment of wet age-related macular degeneration... Continue reading
Posted 2 days ago at Policy and Medicine
Image
Last week, the Justice Department announced that Quest Diagnostics Inc. and Quest Diagnostics Clinical Laboratories Inc. agreed to pay the United States $1.79 million to settle claims that it violated the False Claims Act. Quest operates medical labs where people... Continue reading
Posted 3 days ago at Policy and Medicine
Image
Earlier this year, the Centers for Medicare and Medicaid Services (CMS) added a new star rating system to its Hospital Compare website based on patients’ appraisals. CMS created the HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) Star Ratings... Continue reading
Posted 4 days ago at Policy and Medicine
Image
There is a growing movement in Congress to push the Department of Health and Human Services (HHS) to postpone Stage 3 of the electronic health record meaningful use program. Recently, Rep. Renee Ellmers (R-N.C.) introduced a bill (HR 3309) that... Continue reading
Posted 5 days ago at Policy and Medicine
Image
Yesterday, the Food and Drug Administration (FDA) released much anticipated guidance on how they plan to address nonproprietary naming of biologics and biosimilars. In it, FDA proposed that all biologics—both reference products and biosimilars—will share a core drug substance name... Continue reading
Posted Aug 28, 2015 at Policy and Medicine
Image
Last week, the Federal Trade Commission (FTC) recommended that the Food and Drug Administration (FDA) consider regulating homeopathic products more like other pharmaceuticals. The recommendation is in response to FDA’s call for input on how it regulates homeopathic products—the first... Continue reading
Posted Aug 27, 2015 at Policy and Medicine
Image
A recent article in Reuters shed an interesting and potentially disturbing light on the “medical lending” industry, which operates in some cases by funding surgeries for patients involved in litigation over allegedly defective medical devices. The article focused on pelvic... Continue reading
Posted Aug 26, 2015 at Policy and Medicine
Image
Yesterday, British Health Secretary Jeremy Hunt announced that all National Health Service hospitals and General Practitioner groups will be required to keep a list of every gift and payment from pharmaceutical companies to health service staff. Under the new “Sunshine... Continue reading
Posted Aug 25, 2015 at Policy and Medicine
Image
New York’s Attorney General recently announced an agreement with Purdue Pharma, the manufacturer of OxyContin, that holds the company to a long list of requirements aimed at stemming the recent increase in opioid addiction and opioid-related deaths. The settlement resolves... Continue reading
Posted Aug 24, 2015 at Policy and Medicine
Image
As we previously published, on July 15, 2015, the Centers for Medicare & Medicaid Services (CMS) published its proposed rule to update the Medicare physician fee schedule for 2016. Among the many proposals, CMS seeks comment on whether to add... Continue reading
Posted Aug 21, 2015 at Policy and Medicine
Image
Earlier this week, Amgen Inc. agreed to pay $71 million to 48 states to settle allegations that it violated state consumer protection laws by promoting its anemia drug Aranesp and plaque psoriasis drug Enbrel off-label. Amgen pleaded guilty in 2012... Continue reading
Posted Aug 20, 2015 at Policy and Medicine
Image
Hundreds of people flocked to Washington, DC this week for a three-day conference on Open Payments reporting and associated state and international transparency initiatives. CBI’s Ninth Annual Transparency and Aggregate Spend Conference featured keynote speaker Doug Brown, the Group Director... Continue reading
Posted Aug 19, 2015 at Policy and Medicine
Image
Could the Sunshine Act be creating an unintentional downward trend in clinical research? An analysis of the U.S. government’s Open Payments database shows that industry spending on U.S-based clinical research has dropped 32 percent in the first year-over-year comparison since... Continue reading
Posted Aug 18, 2015 at Policy and Medicine
Image
The August issue of Life Science Compliance Update provides an interesting look at the recently released 2014 Open Payments data. One article outlines the drastic decline in research payments from 2013. Another looks into what manufacturers are writing in Open... Continue reading
Posted Aug 18, 2015 at Policy and Medicine
Image
Last week, the Department of Health and Human Services Office of Inspector General (OIG) followed up on its recent scrutiny into physician-owned distributorships (PODS) with a study entitled “Overlap Between Physician-Owned Hospitals and Physician-Owned Distributors.” In it, OIG reviewed 12... Continue reading
Posted Aug 17, 2015 at Policy and Medicine
Image
On August 12, the American Board of Internal Medicine (ABIM) and the Accreditation Council for Continuing Medical Education (ACCME) announced a collaboration to support physicians who are engaged in lifelong learning by enabling them to use those activities to satisfy... Continue reading
Posted Aug 14, 2015 at Policy and Medicine
Image
The Food and Drug Administration (FDA) has evidently been keeping a close eye on Kim Kardashian’s social media pages. The agency recently issued a Warning Letter targeting posts from Kardashian that promoted Diclegis, a morning sickness medication by Duchesnay, Inc.... Continue reading
Posted Aug 13, 2015 at Policy and Medicine
Image
ProPublica Surgeon Scorecard Ad A major concern surrounding ProPublica’s recently released “Surgeon Scorecard” is that rating physicians in a public database solely on complication rates may discourage surgeons from operating on high-risk patients. The fear, it turns out, is a... Continue reading
Posted Aug 12, 2015 at Policy and Medicine
Image
A number of important healthcare decisions have come out of the Southern District of New York over the last week. Yesterday, we wrote about the Amarin case, where the court held that a firm may promote truthful and non-misleading off-label... Continue reading
Posted Aug 11, 2015 at Policy and Medicine
Image
On Friday, a New York Federal Judge ruled that Amarin Pharma is allowed to promote Vascepa, the company's Omega 3 product used to control triglyceride levels, beyond the currently approved FDA labeling. In the 69-page opinion of this closely-watched case... Continue reading
Posted Aug 10, 2015 at Policy and Medicine
Image
Gilead’s Hepatitis C drugs Sovaldi and Harvoni are often targeted for their upfront price, rather than their long-term benefits for patients. Some states are pushing for legislation which would require drug companies to disclose their costs associated with the drug,... Continue reading
Posted Aug 7, 2015 at Policy and Medicine
Image
The Office of Inspector General of the U.S. Department of Health and Human Services recently released a report seeking to find out the extent to which individual providers who are terminated for cause from one or more State Medicaid programs... Continue reading
Posted Aug 5, 2015 at Policy and Medicine
Image
The Centers for Medicare and Medicaid Services (CMS) recently published the 2014 payment data detailing in a searchable database the transfers of value drug and device manufacturers make to physicians and teaching hospitals. While manufacturers alone are responsible for collecting... Continue reading
Posted Aug 5, 2015 at Policy and Medicine